Search Results

Linagliptin 100 mg  | 99.15%

TargetMol

Linagliptin is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.

More Information Supplier Page

Ranolazine dihydrochloride 100 mg  | 100.00%

TargetMol

Ranolazine(RS-43285), an antianginal agent, can treat arrhythmia via a novel mechanism of action (inhibition of the late phase of the inward sodium current), and do not affect blood pressure or heart rate.

More Information Supplier Page

Ranolazine dihydrochloride 200 mg  | 100.00%

TargetMol

Ranolazine(RS-43285), an antianginal agent, can treat arrhythmia via a novel mechanism of action (inhibition of the late phase of the inward sodium current), and do not affect blood pressure or heart rate.

More Information Supplier Page

Ranolazine dihydrochloride 50 mg  | 100.00%

TargetMol

Ranolazine(RS-43285), an antianginal agent, can treat arrhythmia via a novel mechanism of action (inhibition of the late phase of the inward sodium current), and do not affect blood pressure or heart rate.

More Information Supplier Page

Nylidrin hydrochloride 200 mg  | 100.00%

TargetMol

Nylidrin hydrochloride was an effective inhibitor of the IgG1-mediated release of histamine from passively sensitized guinea pig lung slices, and of the IgE-mediated release of histamine from passively sensitized rat peritoneal mast cells and human basophils.

More Information Supplier Page